By 2040, experts estimate that nearly 400,000 people worldwide will be living with amyotrophic lateral sclerosis (ALS), ...

The blood test, with more than 98% accuracy, opens new avenues for early diagnosis, improved patient care, and potential treatment of the neurodegenerative disease ...

Current ALS diagnosis relies on neurological evaluations and the presence of symptoms, with no definitive diagnostic test ...

Learn how to get involved in clinical trials for amyotrophic lateral sclerosis (ALS), what they entail, and what questions to ask.

About 20% of ALS cases today have a known genetic underpinning, but experts are discovering new mutations — and drug targets — every year.

Researchers have identified a distinct set of proteins in blood that can detect ALS with remarkable accuracy up to a decade ...

New insights reveal how early intervention in radiologically isolated syndrome can delay multiple sclerosis (MS) onset and ...

"I was devastated... My husband and I cried and grieved the loss of the life we had planned together." View Entire Post › ...

U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.

FDA acceptance enables initiation of a Phase 2 multicenter, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of COYA 302 in patients with ALS Arun Swaminathan, Chief ...

The Huntington's Disease Society of America is raising awareness for a fatal genetic disorder called Huntington's Disease.

When Robert F. Kennedy Jr. was named secretary of Health and Human Services, Calley Means, a former Republican lobbyist, ...